ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

NCAB Votes Down Dietary Fat Study In women; Proposal highly Recommended By Study Section

September 29, 1989

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement

September 12, 1986